A RANDOMIZED TRIAL OF ORAL 5-FLUOROURACIL VERSUS PLACEBO AS ADJUVANT THERAPY IN COLORECTAL-CANCER DUKES-B AND DUKES-C - RESULTS AFTER 5 YEARS OBSERVATION TIME

被引：34

作者：

HAFSTROM, L

RUDENSTAM, CM

DOMELLOF, L

机构：

来源：

关键词：

D O I：

10.1002/bjs.1800720223

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

引用

页码：138 / 141

页数：4

共 14 条

[1]

BERGE T, 1973, ACTA CHIR SCAND S, V438

[2] The classification of cancer of the rectum [J].

Dukes, CE .

JOURNAL OF PATHOLOGY AND BACTERIOLOGY, 1932, 35 (03) :323-332

[3]

FRIEDMAN H, 1980, INT C SERIES, V542

[4]

GRAGE TB, 1981, SURG CLIN N AM, V61, P1321

[5]

HIGGINS GA, 1978, CANCER CLIN TRIALS, V1, P35

[6]

KISNER DL, 1981, RECENT RESULTS CANC, V79, P28

[7]

LEE E T, 1972, Computer Programs in Biomedicine, V2, P315, DOI 10.1016/0010-468X(72)90019-0

[8]

MANSOUR EG, 1981, PROGR PERSPECTIVES T, P68

[9]

MITTELMAN A, 1981, ADJUVANT THERAPY CAN, V3, P547

[10]

SKIPPER HE, 1978, CANCER, V41, P936, DOI 10.1002/1097-0142(197803)41:3<936::AID-CNCR2820410322>3.0.CO